| Phase 31 trial |
|
Phase 3
|
NCT00003593 |
Jun 1999 → Mar 2007 |
leukemia, myelodysplastic syndrome, myelodysplastic/myeloproliferative neoplasm |
Children's Oncology Group |
Completed
|
No outcome recorded
|
| Phase not applicable1 trial |
| — |
NCT00096135 |
Nov 2004 → Sep 2013 |
leukemia |
Children's Oncology Group |
Completed
|
No outcome recorded
|
| Comparator or background therapy18 trials |
|
Phase 1
|
NCT07498465 Background |
Sep 2026 → Nov 2028 |
childhood acute lymphoblastic leukemia, childhood acute myeloid leukemia, mixed phenotype acute leukemia |
Children's Oncology Group |
Withdrawn
|
No outcome recorded
|
|
Phase 1/2
|
NCT00098839 Background |
Feb 2005 → Apr 2011 |
childhood acute lymphoblastic leukemia |
Children's Oncology Group |
Completed
|
No outcome recorded
|
|
Phase 1/2
|
NCT00005802 Background |
Jun 1999 → Mar 2005 |
leukemia |
Fred Hutchinson Cancer Center |
Completed
|
No outcome recorded
|
|
Phase 2
|
NCT06317662 Background |
Jun 2025 → Dec 2028 expected |
B-cell acute lymphoblastic leukemia, acute leukemia of ambiguous lineage |
National Cancer Institute (NCI) |
Recruiting
|
No outcome recorded
|
|
Phase 2
|
NCT01700946 Comparator |
Apr 2013 → Jul 2021 |
B-cell childhood acute lymphoblastic leukemia |
St. Jude Children's Research Hospital |
Completed
|
No outcome recorded
|
|
Phase 2
|
NCT00873093 Background |
Mar 2009 → Sep 2014 |
B-cell adult acute lymphocytic leukemia, B-cell childhood acute lymphoblastic leukemia, T-cell adult acute lymphocytic leukemia, T-cell childhood acute lymphocytic leukemia |
National Cancer Institute (NCI) |
Completed
|
No outcome recorded
|
|
Phase 2
|
NCT00084838 Background |
Feb 2003 → Feb 2008 |
central nervous system cancer |
Dana-Farber Cancer Institute |
Completed
|
No outcome recorded
|
|
Phase 2
|
NCT00002785 Background |
Jul 1996 → Aug 2000 |
leukemia |
Children's Oncology Group |
Completed
|
No outcome recorded
|
|
Phase 2
|
NCT00002552 Background |
Oct 1993 → Sep 2001 |
plasma cell neoplasm |
Barbara Ann Karmanos Cancer Institute |
Completed
|
No outcome recorded
|
|
Phase 3
|
NCT03007147 Background |
Aug 2017 → Sep 2027 expected |
B-cell acute lymphoblastic leukemia, T-cell acute lymphoblastic leukemia, mixed phenotype acute leukemia |
Children's Oncology Group |
Active not recruiting
|
No outcome recorded
|
|
Phase 3
|
NCT02101853 Background |
Dec 2014 → Jun 2021 overdue |
B-cell acute lymphoblastic leukemia |
National Cancer Institute (NCI) |
Active not recruiting
|
Missed primary
|
|
Phase 3
|
NCT00557193 Background |
Jan 2008 → Sep 2017 |
T-cell childhood acute lymphocytic leukemia, acute undifferentiated leukemia |
Children's Oncology Group |
Completed
|
No outcome recorded
|
|
Phase 3
|
NCT00400946 Background |
Apr 2005 → Aug 2014 |
leukemia, poisoning |
Dana-Farber Cancer Institute |
Completed
|
No outcome recorded
|
|
Phase 3
|
NCT00002816 Background |
Dec 1996 → Nov 2002 |
acute leukemia |
Children's Oncology Group |
Completed
|
No outcome recorded
|
|
Phase 3
|
NCT00002855 Background |
Aug 1996 → Jun 2005 |
prostate cancer |
M.D. Anderson Cancer Center |
Completed
|
Missed primary
|
|
Phase 3
|
NCT00002798 Background |
Aug 1996 → Sep 2006 |
acute erythroid leukemia, acute monocytic leukemia, acute myeloblastic leukemia with maturation, acute myeloblastic leukemia without maturation +8 |
National Cancer Institute (NCI) |
Completed
|
No outcome recorded
|
|
Phase 3
|
NCT01230983 Background |
Jun 1996 → Sep 2001 |
acute leukemia, chemotherapy-induced toxicity, lymphoma |
Children's Oncology Group |
Completed
|
No outcome recorded
|
| — |
NCT00550992 Background |
Jan 2006 → Dec 2020 |
leukemia |
Dutch Childhood Oncology Group |
Unknown
|
Missed primary
|
|